Uterine Cancer On the Rise Highlighting Drastic Disparities Among Black and Hispanic/LatinX Women

Cancer experts are ringing alarm bells due to the rise in uterine cancer.
Uterine cancer is on the rise highlighting drastic disparities among women of color.
Cancer experts are ringing alarm bells due to the rise in uterine cancer.
Black women with uterine cancer die at twice the rate of white women according to a new study published in JAMA Oncology. This represents one of the largest gaps in cancer disparities. It was also found that Black women are more likely to have to have a more aggressive non-endometrioid type that is correlated with obesity.
Black and Hispanic women were "less likely than white women to undergo hysterectomy, less likely to have their lymph nodes properly biopsied to see if the cancer had spread and less likely to receive chemotherapy, even for a more threatening cancer."
This report also provides personal experiences of women who were brushed off when they pursued treatment for abnormal uterine bleeding, especially if they did not have insurance.
One story highlighted the fact that many women have not been educated about the most important symptom of uterine cancer, vaginal bleeding after menopause. This leads to deadly delays in diagnosis.
This new research, and the stories shared here, should raise concern among clinicians and researchers.
-
This content has been reviewed by the Laura W. Bush Institute for Women’s Health Scientific Council and is not meant to serve as medical advice or replace the opinion of your healthcare provider.
Related Stories
TTUHSC Researcher Receives National Award
The AACR presented its Minority-Serving Institution Faculty Scholar in Cancer Research Award to TTUHSC Associate Professor Duke Appiah, Ph.D., MPH, at the AACR 2025 Annual Meeting in Chicago recently.
TTUHSC Teams Selected for 2025 Innosphere Life Sciences Accelerator Cohort
A pair of teams representing TTUHSC earned a spot among the 33 startup groups selected for the 2025 cohort of the Innosphere Life Sciences Accelerator.
Exploring New Frontiers in Patient Care
Jenna Kesey, Ph.D., associate managing director for the Clinical Research Institute (CRI) at TTUHSC, said it's important that the university provides opportunities for its patients to have access to innovative therapies through the clinical trial process.
Recent Stories
TTUHSC Teams Selected for 2025 Innosphere Life Sciences Accelerator Cohort
A pair of teams representing TTUHSC earned a spot among the 33 startup groups selected for the 2025 cohort of the Innosphere Life Sciences Accelerator.
Exploring New Frontiers in Patient Care
Jenna Kesey, Ph.D., associate managing director for the Clinical Research Institute (CRI) at TTUHSC, said it's important that the university provides opportunities for its patients to have access to innovative therapies through the clinical trial process.
Willed Body Memorial Service Honors Those Who Donated
On Memorial Day each May, a service is conducted at the Texas Tech University Health Sciences Center Institute of Anatomical Sciences to pay respect to the Willed Body Program donors and their families.